Project R-16235
Title
MS-Observe: real world insights into ofatumumab treatment in Belgium (Research)
Abstract
MS-Observe is a national study using real world clinical data to better understand the characteristics and outcomes of patients receiving ofatumumab. The project collaborates with Belgian MS centers to collect and standardize aggregated datasets. It aims to describe the treated population, explore reasons for therapy switches, and assess treatment effectiveness using routinely collected clinical measures. Findings will be summarized in an aggregated report for the sponsor.
Period of project
03 November 2025 - 02 September 2027